Spiriva vs Wixela
What to choose Spiriva or Wixela
Spiriva and Wixela are inhalers both of Control type. Spiriva and Wixela are both brand inhalers. Spiriva is manufactured by pharmaceutical company Boehringer Ingelheim, while Wixela is manufactured by Viatris. The main substance of Spiriva is Tiotropium. The available dosage for Spiriva is 9 mcg. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50.
The average price for Spiriva is approximately $423 per inhaler while average price for Wixela is around $240 per inhaler, said Adonis Peterson, a Lecturer at the Adelphi University and an Advanced Medical Support Assistant at a clinic that uses Spiriva and Wixela.
Spiriva and Wixela Comparison
| Spiriva | Wixela | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Boehringer Ingelheim | Viatris |
| Substance: | Tiotropium | Fluticasone + Salmeterol |
| Dosage: | 9 mcg | 250/50 |
| Avg Price: | $423 | $240 |